Skip to end of metadata
Go to start of metadata

1a. Project Name

Situation Awareness for Novel Epidemic Response FHIR IG

1b. Project ID


1c. Is Your Project an Investigative Project (aka PSS-Lite)?


1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?


1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Patient Administration

2b. Co-Sponsor WG

Orders & Observations

2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2c. Co-Sponsor Update Periods


2b. Co-Sponsor WG 2

Public Health

2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2c. Co-Sponsor 2 Update Periods


2d. Project Facilitator

David Pyke

2e. Other Interested Parties (and roles)

2f. Modeling Facilitator

2g. Publishing Facilitator

Alex De Leon

2h. Vocabulary Facilitator

2i. Domain Expert Representative

2j. Business Requirements Analyst

2k. Conformance Facilitator

David Pyke

2l. Other Facilitators

2m. Implementers

Cerner, EPIC, Microsoft,others

3a. Project Scope

The Situational Awareness for Novel Epidemic Response Implementation Guide enables transmission of high level situational awareness information from initially inpatient facilities to centralized data repositories to support the focus and response to novel influenza-like illness, such as COVID-19.

The goal of publishing this guide is to encourage the creation of a community interested in extremely rapid development of interfaces that can support communication of aggregate patient status and outcome measures, bed, ventilator, and other resource measures, as well as test order and result measures to national, state, or local Public Health agencies/jurisdictions in this time of crisis. This project will focus on current and draft FHIR resources with possible new extensions.

This scope was initially established to address US reporting requirements by FEMA, CDC to address COVID-19. However, other state, local, and additional countries' jurisdictional reporting needs are expected to be included as well as the project team expands as the pandemic is global. Nor are related or other outbreaks are not excluded from the scope. Other projects that may overlap will be considered as needed.


3b. Project Need

COVID-19 has caused a need to have immediate awareness of available aggregate status, outcome, and resources for public health and other group monitoring, coordinating, and directing a course of action. Related and future outbreaks can immediately benefit from the work in this project be further prepared.

3c. Security Risk


3d. External Drivers

3e. Objectives/Deliverables and Target Dates

A FHIR IG for resource availability reporting
Dates TBD

3f. Common Names / Keywords / Aliases:

Situation Awareness for Novel Epidemic Response

3g. Lineage

3h. Project Dependencies


3i. HL7-Managed Project Document Repository URL:

3j. Backwards Compatibility


3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?


3l. Reason for not using current V3 data types?

3m. External Vocabularies


3n. List of Vocabularies

3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

FHIR Extensions, FHIR Implementation Guide, FHIR Profiles

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?


4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Implementation Guide (IG) will be created/modified

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?


5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

5b. Project Ballot Type

STU to Normative

5c. Additional Ballot Info

5d. Joint Copyright


5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.


6a. External Project Collaboration

6b. Content Already Developed


6c. Content externally developed?


6d. List Developers of Externally Developed Content

Keith Boone, Audacious Inquiry
Josh Mandel, Microsoft
Dave Pyke, Ready Computing
Many others

6e. Is this a hosted (externally funded) project?


6f. Stakeholders

Clinical and Public Health Laboratories, Immunization Registries, Regulatory Agency, Payors

6f. Other Stakeholders

6g. Vendors

EHR, PHR, Health Care IT, Lab, HIS

6g. Other Vendors

6h. Providers

Clinical and Public Health Laboratories, Emergency Services, Local and State Departments of Health, Healthcare Institutions (hospitals, long term care, home care, mental health)

6h. Other Providers

6i. Realm


7d. US Realm Approval Date

7a. Management Group(s) to Review PSS


7b. Sponsoring WG Approval Date

Mar 25, 2020

7c. Co-Sponsor Approval Date

Mar 26, 2020

7c. Co-Sponsor 2 Approval Date

Apr 02, 2020

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

Apr 01, 2020

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

Apr 03, 2020

7j. TSC Approval Date

Apr 06, 2020

 Show Changes